About Medeor Therapeutics
Medeor Therapeutics is a company based in San Mateo (United States) founded in 2014.. Medeor Therapeutics has raised $57 million across 2 funding rounds from investors including RA Capital, CIRM and Sofinnova. Medeor Therapeutics offers products and services including Lottery Results Service, Toto HK Data, and Pengeluaran HK. Medeor Therapeutics operates in a competitive market with competitors including NuVasive, Ensoma, GigaGen, Nohla Therapeutics and Xenikos, among others.
- Headquarter San Mateo, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$57 M (USD)
in 2 rounds
-
Latest Funding Round
$18.8 M (USD), Grant
Jan 22, 2018
-
Investors
RA Capital
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Medeor Therapeutics
Medeor Therapeutics offers a comprehensive portfolio of products and services, including Lottery Results Service, Toto HK Data, and Pengeluaran HK. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides official Hong Kong lottery results for player access
Offers historical and live data for Hong Kong Toto games
Delivers real-time lottery output data for bettors
Funding Insights of Medeor Therapeutics
Medeor Therapeutics has successfully raised a total of $57M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $18.8 million completed in January 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $18.8M
-
First Round
First Round
(27 Nov 2017)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2018 | Amount | Grant - Medeor Therapeutics | Valuation |
investors |
|
| Nov, 2017 | Amount | Series B - Medeor Therapeutics | Valuation | RA Capital Management |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Medeor Therapeutics
Medeor Therapeutics has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include RA Capital, CIRM and Sofinnova. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biotech funding, drug development support, and investment in life sciences.
|
Founded Year | Domain | Location | |
|
Life-Sciences focused early and growth stage VC firm funding companies in China & the US
|
Founded Year | Domain | Location | |
|
Venture capital and private equity firm
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Medeor Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Medeor Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Medeor Therapeutics Comparisons
Competitors of Medeor Therapeutics
Medeor Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NuVasive, Ensoma, GigaGen, Nohla Therapeutics and Xenikos, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Smart surgical devices for spinal surgery are developed.
|
|
| domain | founded_year | HQ Location |
Provider of in vivo stem cell modification technologies and vector-based drug delivery tool
|
|
| domain | founded_year | HQ Location |
T-cell and antibody-based therapeutics are developed via single-cell sequencing platforms.
|
|
| domain | founded_year | HQ Location |
Develops stem-cell transplant solutions using umbilical cord blood as an alternative to bone-marrow transplants.
|
|
| domain | founded_year | HQ Location |
Developer of toxin-loaded antibodies for T-cell mediated diseases
|
|
| domain | founded_year | HQ Location |
Therapeutics for immune diseases are developed via targeted immunomodulators.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Medeor Therapeutics
Frequently Asked Questions about Medeor Therapeutics
When was Medeor Therapeutics founded?
Medeor Therapeutics was founded in 2014 and raised its 1st funding round 3 years after it was founded.
Where is Medeor Therapeutics located?
Medeor Therapeutics is headquartered in San Mateo, United States. It is registered at San Mateo, California, United States.
Is Medeor Therapeutics a funded company?
Medeor Therapeutics is a funded company, having raised a total of $57M across 2 funding rounds to date. The company's 1st funding round was a Series B of $57M, raised on Nov 27, 2017.
What does Medeor Therapeutics do?
Medeor Therapeutics was founded in 2014 in San Mateo, United States, within the biotechnology sector. Personalised cellular therapeutics are developed to support kidney transplant recipients and organs. The lead product, MDR-101, is manufactured from peripheral blood stem cells derived from transplant kidney donors, aiming to reduce reliance on anti-rejection drugs and their side effects. Exclusive worldwide licenses to technologies discovered at Stanford University are held by the company.
Who are the top competitors of Medeor Therapeutics?
What products or services does Medeor Therapeutics offer?
Medeor Therapeutics offers Lottery Results Service, Toto HK Data, and Pengeluaran HK.
Who are Medeor Therapeutics's investors?
Medeor Therapeutics has 5 investors. Key investors include RA Capital, CIRM, Sofinnova, 6 Dimensions Capital, and Vivo Capital.